Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Rubius Therapeutics CEO and leadership

Zippia score 4.5
OverviewSalaryRevenueReviewsHistoryCompetitors

CEO & Executives

Rubius Therapeutics CEO and executives

Executive Summary. Based on our data team's research, Pablo J. Cagnoni M.d is the Rubius Therapeutics's CEO. Rubius Therapeutics has 200 employees, of which 37 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Rubius Therapeutics executive team is 46% female and 54% male.
  • 59% of the management team is White.
  • 14% of Rubius Therapeutics management is Hispanic or Latino.
  • 9% of the management team is Black or African American.
Work at Rubius Therapeutics?
Share your experience

Rate Rubius Therapeutics' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Pablo J. Cagnoni M.d

CEO

Pablo J. Cagnoni M.d's LinkedIn

Pablo Cagnoni joined Rubius Therapeutics as Chief Executive Officer in June 2018. Over the course of Pablo’s career as an oncologist and pharmaceutical executive, he has been committed to advancing the development of breakthrough treatments for people with cancer and other diseases. He has played a key role in the development, approval and commercialization of more than 20 life-changing treatments, including Afinitor®, Kyprolis® and Tarceva®.

Noubar Afeyan Ph.d.

Chairman

Laurence Turka M.d

Chief Scientific Officer

Laurence Turka, M.D., joined Rubius as Chief Scientific Officer in January 2020. Larry is an internationally recognized, physician-scientist in autoimmunity and translational immunology with a distinguished career working in academia and, more recently, industry.

Avak Kahvejian

Founder

Vijay K. Kuchroo

Board Member

David R. Epstein

Board Member

Maiken Keson-Brookes

Chief Legal Officer and Corporate Secretary

Maiken Keson-Brookes's LinkedIn

Maiken Keson-Brookes is a Senior VP/General Counsel at ForumPharma and Chief Legal Officer/Secretary at Rubius Therapeutics and is based in Watertown Town, Massachusetts. She has worked as Senior VP/General Counsel at uniQure N.V., Legal Counsel at CIMS, and Legal & Consular Officer at Royal Danish Embassy. Maiken Keson works or has worked as SVP and General Counsel at Envivo Pharmaceuticals and Associate General Counsel at BIOGEN INC.. She studied at King's College London.

Michael A. Rosenblatt

Board Member

Francis M. Cuss

Board Member

Jonathan Richard Symonds

Board Member

Do you work at Rubius Therapeutics?

Does the leadership team provide a clear direction for Rubius Therapeutics?

Rubius Therapeutics jobs

Rubius Therapeutics founders

Name & TitleBio
Noubar Afeyan Ph.d.

Chairman

Laurence Turka M.d

Chief Scientific Officer

Laurence Turka, M.D., joined Rubius as Chief Scientific Officer in January 2020. Larry is an internationally recognized, physician-scientist in autoimmunity and translational immunology with a distinguished career working in academia and, more recently, industry.

Avak Kahvejian

Founder

Rubius Therapeutics board members

Name & TitleBio
Pablo J. Cagnoni M.d

CEO

Pablo J. Cagnoni M.d's LinkedIn

Pablo Cagnoni joined Rubius Therapeutics as Chief Executive Officer in June 2018. Over the course of Pablo’s career as an oncologist and pharmaceutical executive, he has been committed to advancing the development of breakthrough treatments for people with cancer and other diseases. He has played a key role in the development, approval and commercialization of more than 20 life-changing treatments, including Afinitor®, Kyprolis® and Tarceva®.

Noubar Afeyan Ph.d.

Chairman

Laurence Turka M.d

Chief Scientific Officer

Laurence Turka, M.D., joined Rubius as Chief Scientific Officer in January 2020. Larry is an internationally recognized, physician-scientist in autoimmunity and translational immunology with a distinguished career working in academia and, more recently, industry.

Vijay K. Kuchroo

Board Member

David R. Epstein

Board Member

Michael A. Rosenblatt

Board Member

Francis M. Cuss

Board Member

Jonathan Richard Symonds

Board Member

Natalie C. Holles

Board Member

Anne Prener

Board Member

Rubius Therapeutics executives FAQs

Related company executives

Working at related companies

Related company jobs

Rubius Therapeutics highest paying jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of Rubius Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Rubius Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Rubius Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Rubius Therapeutics. The data presented on this page does not represent the view of Rubius Therapeutics and its employees or that of Zippia.

Rubius Therapeutics may also be known as or be related to RUBIUS THERAPEUTICS, INC., Rubius Therapeutics, Rubius Therapeutics Inc and Rubius Therapeutics, Inc.